C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 413/14 (2006.01) A61K 31/4245 (2006.01) A61P 19/00 (2006.01) C07D 271/08 (2006.01) C07D 413/12 (2006.01)
Patent
CA 2613607
Disclosed are compounds of the formula (1). and the pharmaceutically acceptable salts thereof. X is N or N+O-, and Y is N or N+O-, provided that at least X or Y is N. The compounds are useful for the treatment of chemokine- mediated diseases such as COPD.
La présente invention se rapporte à des composés représentés par la formule (1) ainsi qu'à des sels pharmaceutiquement acceptables de ces composés. Dans ladite formule X est N ou N+O-, et Y est N ou N+O-, à condition qu'au moins X ou Y soit N. Ces composés s'avèrent utiles pour le traitement des maladies à médiation par des chimiokines, par exemple la broncho-pneumopathie chronique obstructive (PBCO).
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
Schering Corporation
LandOfFree
Di-substituted oxadiazoles as cxc-chemokine receptor ligands does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Di-substituted oxadiazoles as cxc-chemokine receptor ligands, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Di-substituted oxadiazoles as cxc-chemokine receptor ligands will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1681889